Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-28

FDA Approved: SODIUM POLYSTYRENE SULFONATE — Original Application (SUNRISE PHARMACEUTICAL, INC.)

View source ↗

Summary

FDA approved Sunrise Pharmaceutical, Inc.'s original application for sodium polystyrene sulfonate, a resin used to treat hyperkalemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium polystyrene sulfonate (Sodium polystyrene sulfonate)

Snippet

ORIG AP for SODIUM POLYSTYRENE SULFONATE (SODIUM POLYSTYRENE SULFONATE)